Results 291 to 300 of about 414,323 (331)

Hematopathology Practice in the Digital Era: What has Changed?

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Hematopathology workflows are complex, since they include numerous data points necessary for guiding further testing, diagnosis, and patient management. The workflows start with complete blood cell counts, with subsequent morphologic evaluation of peripheral blood (PB) and bone marrow (BM).
Olga Pozdnyakova
wiley   +1 more source

Beta-Arrestin 1 Deficiency Enhances Host Anti-Myeloma Immunity Through T Cell Activation and Checkpoint Modulation. [PDF]

Int J Mol Sci
Wu J, Wang X, Jabbar S, Ganesh N, Chu E, Math VT, Rein L, Kang Y.   +7 more
europepmc   +1 more source

The urinary albumin‐to‐creatinine ratio can direct personalized prevention and treatment for cardiovascular and chronic kidney disease

Journal of Internal Medicine, EarlyView.
Abstract Increased urinary albumin excretion is a strong predictor for cardiovascular events in persons with and without decreased glomerular filtration rate and can be assessed with the urinary albumin‐to‐creatinine ratio (UACR), which is a selective, sensitive, and convenient method for patients.
Holly J. Kramer, George L. Bakris
wiley   +1 more source

Peripheral blood immune cell profiling and response to BCMA CAR-T cell therapy in relapsed refractory multiple myeloma. [PDF]

Blood Cancer J
Pandey T, Mohan Lal B, Alrawabdeh J, Alzu'bi M, Schinke CD, Thanendrarajan S, Alapat DV, Shaughnessy JD, Zhan F, Zangari M, van Rhee F, Al Hadidi S.   +11 more
europepmc   +1 more source

CELMoD-antibody conjugates unlock a CD38 feedback loop in multiple myeloma. [PDF]

Acta Pharm Sin B
Jin J.
europepmc   +1 more source

Elevated non-clonal bone marrow plasma cell fraction at diagnosis is associated with improved outcomes in multiple myeloma. [PDF]

Blood Cancer J
Zanwar S, Jevremovic D, Kapoor P, Olteanu H, Buadi F, Horna P, Gonsalves W, Seheult J, Otteson G, Hayman S, Abdallah N, Binder M, Cook J, Dispenzieri A, Dingli D, Dasari S, Gertz MA, Kourelis T, Leung N, Lin Y, Muchtar E, Siddiqui M, Weivoda M, Warsame R, Kyle RA, Rajkumar SV, Kumar S.   +26 more
europepmc   +1 more source

Mechanistic Insights and Advances of Bispecific T Cell Engaging Antibodies Therapy in Multiple Myeloma. [PDF]

Medicina (Kaunas)
Tang TF, Cheong CS, Looi CY, Wong WF, Gan GG.   +4 more
europepmc   +1 more source

The effects of daratumumab on bone disease in patients with newly diagnosed multiple myeloma: a multi-center retrospective study. [PDF]

BMC Cancer
Li X, Wang H, Li Y, Zhou J, Yang N, Wei X, Cai X, Xiao Z, Du J, Zeng H.   +9 more
europepmc   +1 more source